Welcome to LookChem.com Sign In|Join Free

CAS

  • or

91065-17-7

Post Buying Request

91065-17-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91065-17-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91065-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 91065-17:
(7*9)+(6*1)+(5*0)+(4*6)+(3*5)+(2*1)+(1*7)=117
117 % 10 = 7
So 91065-17-7 is a valid CAS Registry Number.

91065-17-7Relevant articles and documents

Novel amidrazone derivatives: Design, synthesis and activity evaluation

Zhou, Hua,Wang, Zhi Sen,Liu, Xin Hua,Chen, Fei Hu

, p. 3158 - 3165 (2018/05/05)

A series of new 6-styryl-naphthalene-2-amidrazone derivatives were synthesized and evaluated as potential ASIC1a inhibitors. Among them, compound 5e showed the most activity to inhibit [Ca2+]i. elevation in acid-induced articular chondrocytes. Together with the important role of ASIC1a in the pathogenesis of tissue acidification diseases including rheumatoid arthritis, these results might provide a meaningful hint or inspiration in developing drugs targeting at tissue acidification diseases.

Nickel-catalyzed cross-couplings of benzylic pivalates with arylboroxines: Stereospecific formation of diarylalkanes and triarylmethanes

Zhou, Qi,Srinivas, Harathi D.,Dasgupta, Srimoyee,Watson, Mary P.

, p. 3307 - 3310 (2013/04/23)

We have developed a stereospecific nickel-catalyzed cross-coupling of benzylic pivalates with arylboroxines. The success of this reaction relies on the use of Ni(cod)2 as the catalyst and NaOMe as a uniquely effective base. This reaction has broad scope with respect to the arylboroxine and benzylic pivalate, enabling the synthesis of a variety of diarylalkanes and triarylmethanes in good to excellent yields and ee's.

ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS

-

, (2012/04/23)

The present invention provides a compound of Formula (I); a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91065-17-7